Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0A8I stock hub

LON/0A8I has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0A8Iis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
6.7M
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0A8I
In the news

Latest news · LON/0A8I

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-338.7
P25 n/aP50 n/aP75 n/a
ROIC-202.4
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0A8I market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
137
Groups with data
11
Currency
USD
Showing 137 of 137 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
UK
Employees
13
Employees Change
-6%
Employees Change Percent
-31.58
Enterprise value
$904,344
Exchange
London Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Isin
US3724463027
Last refreshed
2026-05-10
Market cap
$6.7M
Price
$0.89
Price currency
USD
Sic
2836
Symbol
lon/0A8I
Website
https://www.genprex.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-181.29%
EV Earnings
-0.07x
P/B ratio
1.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

8
MetricValue
Net Income
$-12.1M
Profit Per Employee
$-927,547
ROA
-135.8
Roa5y
-99.02
ROCE
-194.3
ROE
-338.7
Roe5y
-229.2
ROIC
-202.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

3
MetricValue
Cagr1y
-93.78%
Cagr3y
-91.69%
Cagr5y
-83.29%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

16
MetricValue
Assets
$7.5M
Cash
$5.8M
Current Assets
$6.1M
Current Liabilities
$1.6M
Equity
$5.9M
Interest Coverage
-20.97
Liabilities
$1.6M
Long Term Assets
$1.4M
Long Term Liabilities
$37,346
Net Cash
$5.8M
Net Cash By Market Cap
$87.48
Net Cash Growth
388.92%
Net Debt Equity
$-0.98
Tangible Book Value
$5.9M
Tangible Book Value Per Share
$1.8
WACC
-0.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
3.84
Net Working Capital
$-1.2M
Quick ratio
3.6
Working Capital
$4.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-1,063.89%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
-93.77%
200-day SMA
5.54
3Y total return
-99.94%
50-day SMA
1.53
50-day SMA vs 200-day SMA
50under200
5Y total return
-99.99%
All Time High
8,064
All Time High Change
-99.99%
All Time High Date
2021-04-15
All Time Low
0.85
All Time Low Change
4.09%
All Time Low Date
2026-05-08
ATR
0.12
Beta
-0.93
Ch YTD
-48.6
High
0.91
High52
54.6
High52 Date
2025-10-15
High52ch
-98.38%
Low
0.85
Low52
0.85
Low52 Date
2026-05-08
Low52ch
4.09%
Ma50ch
-41.89%
Price vs 200-day SMA
-84%
RSI
31.17
RSI Monthly
23.22
RSI Weekly
30.76
Sharpe ratio
-0.18x
Sortino ratio
-0.41
Total Return
-1,063.89%
Tr YTD
-48.6
Tr1m
-35.31%
Tr1w
-3.14%
Tr3m
-59.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

1
MetricValue
Operating Income
$-11.5M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
10,395,656%
Shares Insiders
0.21%
Shares Institutions
1.03%
Shares Qo Q
177.21%
Shares Yo Y
1,063.89%
Short Ratio
0.55

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

42
MetricValue
Average Volume
30,862.6x
Bv Per Share
1.8
Ch1m
-35.31
Ch1w
-3.14
Ch1y
-93.77
Ch3m
-59.9
Ch3y
-99.94
Ch5y
-99.99
Ch6m
-79
Change
2.44%
Change From Open
-2.08
Close
0.87
Days Gap
4.62
Depreciation Amortization
4,909.4
Dollar Volume
3,948.9
Earnings Date
2026-05-14
EBIT
$-11.5M
EBITDA
$-11.5M
EPS
$-12.93
F Score
2
Financing CF
16,004,520
Fiscal Year End
December
Founded
2,009
Is Primary Listing
0
Last Earnings Date
2025-11-14
Last Report Date
2025-12-31
Last Split Date
2025-10-21
Last Split Type
Reverse
Ma150
3.72
Ma150ch
-76.18%
Ma20
1.04
Ma20ch
-15.11%
Net CF
4,628,292
Next Earnings Date
2026-05-14
Open
0.91
Position In Range
64.93
Price Date
2026-05-08
Ptbv Ratio
1.12
Relative Volume
0.14x
Share Based Comp
232,436
Tr6m
-79%
Volume
4,456
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does LON/0A8I pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0A8I stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-93.8%
S&P 500 1Y: n/a
3Y total return
-99.9%
S&P 500 3Y: n/a
5Y total return
-100.0%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/0A8I?

Insider, institutional, and short-interest positioning.

Institutional ownership
+1.0%
Share of float held by funds and institutions
Insider ownership
+0.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
0.6 days to cover
Y/Y dilution
+1063.9%
Negative means the company is buying back shares.
Technical

LON/0A8I momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
31.2
Neutral momentum band
Price vs 200-day MA
-84.0%
50/200-day relationship not available
Beta (5Y)
-0.93
Less volatile than the market
Sharpe ratio
-0.18
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0A8I

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0A8I stock rating?

lon/0A8I is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0A8I analysis?

The full report lives at /stocks/lon/0A8I/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0A8I?

The latest report frames lon/0A8I around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0A8I page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

lon/0A8I stock profile: metrics, valuation and analysis | Agente AI del Mercato Azionario